Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases due to the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).
The Amyloidosis Center at BMC offers a multi-disciplinary approach to diagnosis and treatment of this multi-organ disorder.
Specialists in hematology-oncology, cardiology, pulmonary medicine, nephrology, gastroenterology, neurology, otolaryngology, urology, and radiation oncology participate in patient evaluation and care. The Amyloidosis Center operates a CLIA-approved diagnostic laboratory.
This video highlights some of the lives Boston Medical Center has touched, including Mark Kimble, a former English teacher from Maine with amyloidosis. He was treated at Boston Medical Center with an aggressive treatment plan that included chemotherapy and stem cell transplant, first pioneered at Boston Medical Center and Boston University School of Medicine. Please click on the image below to play the video: